The first PDL Biopharma trade was made in Q1 2008.
Since then Seth Klarman bought shares six more times and sold shares on six occasions. The investor completely sold their stake between Q4 2011 and Q1 2012.
Avg closing price
Price range
Sold -8M shares
Q1 2012
Avg closing price
$5.91
Price range
$5.63
-
$6.15
Sold 48.8% shares (-7.64M shares)
Q4 2011
Avg closing price
$5.59
Price range
$5.00
-
$5.99
Increased shares by 68.8% (+6.37M shares)
Q3 2011
Avg closing price
$5.51
Price range
$5.12
-
$5.98
Sold 11.7% shares (-1.23M shares)
Q2 2011
Avg closing price
$5.82
Price range
$5.37
-
$6.21
Increased shares by 87.3% (+4.89M shares)
Q1 2011
Avg closing price
$5.01
Price range
$4.39
-
$5.95
New holding (+5.6M shares)
Q4 2010
Avg closing price
$5.36
Price range
$4.82
-
$6.09
Sold -12.7M shares
Q3 2009
Avg closing price
$7.91
Price range
$7.23
-
$8.62
Sold 18.7% shares (-2.9M shares)
Q2 2009
Avg closing price
$6.79
Price range
$6.14
-
$7.44
Increased shares by 8.3% (+1.2M shares)
Q1 2009
Avg closing price
$5.95
Price range
$4.88
-
$6.68
Increased shares by 3.6% (+503k shares)
Q4 2008
Avg closing price
$8.23
Price range
$5.48
-
$9.50
Sold 6.5% shares (-965k shares)
Q3 2008
Avg closing price
$10.28
Price range
$8.39
-
$11.73
Increased shares by 3111.7% (+14.4M shares)
Q2 2008